🇺🇸 FDA
Patent

US 11426373

Gamma-hydroxybutyrate compositions and their use for the treatment of disorders

granted A61KA61K2300/00A61K31/19

Quick answer

US patent 11426373 (Gamma-hydroxybutyrate compositions and their use for the treatment of disorders) held by Jazz Pharmaceuticals Ireland Limited expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jazz Pharmaceuticals Ireland Limited
Grant date
Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2300/00, A61K31/19, A61P, A61P25/00